These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2142607)

  • 1. Effect of fibrinogen degradation products and lung ground substance on surfactant function.
    O'Brodovich HM; Weitz JI; Possmayer F
    Biol Neonate; 1990; 57(6):325-33. PubMed ID: 2142607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer.
    Seeger W; Stöhr G; Wolf HR; Neuhof H
    J Appl Physiol (1985); 1985 Feb; 58(2):326-38. PubMed ID: 3838543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D; Ibrahim M; Wollin L; Germann PG
    Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic cleavage of fibrinogen: amplification of its surfactant inhibitory capacity.
    Seeger W; Grube C; Günther A
    Am J Respir Cell Mol Biol; 1993 Sep; 9(3):239-47. PubMed ID: 8398160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clot-embedded natural surfactant: kinetics of fibrinolysis and surface activity.
    Günther A; Kalinowski M; Elssner A; Seeger W
    Am J Physiol; 1994 Nov; 267(5 Pt 1):L618-24. PubMed ID: 7977772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
    Strayer DS; Herting E; Sun B; Robertson B
    Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoprotein-based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro.
    Günther A; Bleyl H; Seeger W
    Am J Physiol; 1993 Aug; 265(2 Pt 1):L186-92. PubMed ID: 8368328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system].
    Koga Y
    Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant incorporation markedly alters mechanical properties of a fibrin clot.
    Günther A; Kalinowski M; Rosseau S; Seeger W
    Am J Respir Cell Mol Biol; 1995 Dec; 13(6):712-8. PubMed ID: 7576709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant.
    Müller H; End C; Renner M; Helmke BM; Gassler N; Weiss C; Hartl D; Griese M; Hafner M; Poustka A; Mollenhauer J; Poeschl J
    Respir Res; 2007 Oct; 8(1):69. PubMed ID: 17908325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of fibrin degradation products in neutrophil recruitment to the lung.
    Leavell KJ; Peterson MW; Gross TJ
    Am J Respir Cell Mol Biol; 1996 Jan; 14(1):53-60. PubMed ID: 8534486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary surfactant.
    Dobbs LG
    Annu Rev Med; 1989; 40():431-46. PubMed ID: 2658759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damage to surfactant-specific protein in acute respiratory distress syndrome.
    Baker CS; Evans TW; Randle BJ; Haslam PL
    Lancet; 1999 Apr; 353(9160):1232-7. PubMed ID: 10217084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase.
    Pison U; Tam EK; Caughey GH; Hawgood S
    Biochim Biophys Acta; 1989 Sep; 992(3):251-7. PubMed ID: 2775786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pulmonary surfactant function by meconium.
    Moses D; Holm BA; Spitale P; Liu MY; Enhorning G
    Am J Obstet Gynecol; 1991 Feb; 164(2):477-81. PubMed ID: 1992687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen did not affect lung function in surfactant-treated preterm lambs.
    Bhat V; Jobe AH; Wert S; Jesmok GJ; Ikegami M
    Biol Neonate; 2000 Oct; 78(3):212-9. PubMed ID: 11044771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.